During the session, it was planned:
- Preparation of a position paper on the evaluation of the drug Mizetam (ezetimibum + atorvastatin) in the indication: prevention of cardiovascular events, i.e. as replacement treatment in patients with coronary heart disease (CHD, Coronary Heart Disease) and acute coronary syndrome (ACS, Acute Coronary Syndrome) with a history of CHD control. ACS, Acute Coronary Syndrome) with a history of disease control achieved with concomitant use of single active substances in separate drug products, but at the same doses as in the combination product).
- Preparation of a position paper on the Efluelda vaccine for the indication: influenza.
- Preparation of a position paper on the evaluation of the d...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
